SHANDONG XINHUA PHARMACEUTICAL CO financial statements, including revenue, expenses, and profit
The total revenue of 719 for the last quarter is 1.86 B HKD, and it's 14.20% lower compared to the previous quarter. The net income of Q4 24 is 136.20 M HKD.